A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY - Egyptian Knowledge Bank

46639

A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

CHEMERIN IS AN INDISPENSABLE PRE-TREATMENT PREDICTOR OF SOFOSBUVIR, PEGYLATED INTERFERON-ALPHA AND RIBAVIRIN OUTCOMES IN CHRONIC HEPATITIS C EGYPTIAN PATIENTS

Article

Biochemical study on the response to HCV therapy (Velpatasvir containing regimen), (vosevi) among adult patients’ non-responders to treatment in Fayoum Egypt

Article

Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

Article

Comparative Study between Responders and Non Responders Among Patients Treated for Hepatitis C virus Infection

Article

Biochemical markers and physiological functions in Egyptian patients with hepatitis C virus

Article

Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients

Article

Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus

Article

A Study of the Impact of Treatment Response to Direct Acting Antivirals on Serum Lipid Profile in Egyptian Patients with Chronic HCV Infection

Article

The effect of the polymorphism in IL-28B gene on the treatment response of a combined therapy by sofosbuvir and daclatasvir with and without ribavirin in HCV Egyptian patients

Article

Efficacy of Sofosbuvir plus Daclatasvir in Treatment of Chronic HCV Infection in Egyptian Patients: A Prospective Cohort Study